Skip to content
★ Sign in to follow
KW

Klaus W. Wagner

Executive
Inhibrx, Inc.
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€3.5M

Latest filing published 18 Feb 2021 for Inhibrx, Inc., €3.1M.

Filing timeline

BuySale
Klaus W. Wagner

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

Klaus W. Wagner: trading record in brief

Klaus W. Wagner appears in our data through filings on Inhibrx, Inc. shares, published by SEC (Form 4). Between 16 February 2021 and 17 February 2021, the trades on record add up to 2 filings.

No open-market purchase appears, only 2 sales worth €3.5M.

The newest entry dates from 18 February 2021: an open-market sale of €3.1M, in Inhibrx, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Klaus W. Wagner

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▼
    Chief Medical OfficerExecutivesInhibrx, Inc.
    4M USD31SEC
    156,474 shares@ US$24.3288.5% of flowCommon StockSEC:0001739614-21-000039:0
  • ▼
    Chief Medical OfficerExecutivesInhibrx, Inc.
    494,647 USD24SEC
    19,559 shares@ US$25.2911.5% of flowCommon StockSEC:0001739614-21-000039:1

2 of 2 declarations